Index of Articles From Journal Watch

Please note that some of the links below will take you to articles on TheBodyPRO.com, TheBody.com's sister site for health care professionals.

• How Often Do You Measure CD4 Cell Counts? (March 28, 2013)
• Really Rapid Review: CROI 2013, Atlanta (March 10, 2013)
• Exploring the Media Fascination With the Baby Cured of HIV (March 5, 2013)
• CROI at 20: A Look Back (February 28, 2013)
• An Adherence Intervention That Works -- But There's a Catch (February 17, 2013)
• Medication Adherence: The Final Frontier (February 14, 2013)
• More Evidence That Early HIV Treatment -- REALLY Early -- Is Beneficial (January 16, 2013)
• HIV Exceptionalism is Alive and Well -- and That's Too Bad (January 9, 2013)
• What's a Fulyzaq? I Thought You'd Never Ask (January 3, 2013)
• HIV Incidence: The Latest Numbers (January 1, 2013)
• The U.S. Preventive Services Task Force Recommends HIV Screening -- And Why Is This News? (November 22, 2012)
• The 800-mg Darunavir Tablet Arrives, and Scoring the Top Protease Inhibitors (November 18, 2012)
• Vitamins and the Department of Bad Timing (November 7, 2012)
• Antiretroviral Rounds: Resistance on Two Fronts (November 2, 2012)
• Dolutegravir and the 88 Percent Rule (October 28, 2012)
• Can a "Treat Everyone With HIV" Policy Actually Work? In San Francisco, Yes (October 22, 2012)
• It's Time to Tell Our Patients to Stop Their Vitamin Supplements (October 17, 2012)
• It's Time to Dump the HIV Western Blot (September 19, 2012)
• Thoughts on "Quad" Approval by FDA (August 28, 2012)
• New PrEP "Guidance" Released by CDC (August 9, 2012)
• Really Rapid Review: 2012 International AIDS Conference, Washington, D.C. (August 1, 2012)
• AIDS Quilt, the Early 1990s and Sadness (July 25, 2012)
• IAS-USA HIV Guidelines Updated (July 23, 2012)
• Home HIV Test Big News -- But Why? And What Impact Will It Have? (July 5, 2012)
• "HAART Era" Now Longer Than "Pre-HAART Era" -- Can We Officially Retire "HAART"? (July 1, 2012)
• HIV Testing Roundup, and a Brief Rant (June 29, 2012)
• Questions About HIV Cure, and a Very Funny Quote (June 13, 2012)
• SPARTAN: Two-Drug, NRTI-Sparing Strategies Continue to Disappoint (June 8, 2012)
• Cryptococcal Meningitis Study Stopped -- Early HIV Therapy Clearly Harmful (June 2, 2012)
• Generic Nevirapine Now Available -- But the Big One Is Next Year (May 25, 2012)
• Advisory Meeting May 10 on Tenofovir/FTC for PrEP, and a Proposed "Niche" for its Use (May 10, 2012)
• Do We Really Need Primary Prophylaxis for OIs Anymore? (April 30, 2012)
• An Answer to a Commonly Asked Question: Is Treatment 100% Effective in Preventing HIV Transmission? (April 23, 2012)
• EASL Starts Tomorrow -- Get Ready for the HCV Treatment Deluge (April 17, 2012)
• A Skeptical Look at "Test and Treat" (April 10, 2012)
• Latest Guidelines Recommend HIV Treatment for All (March 27, 2012)
• More Confusion on Anal Cancer Screening (March 22, 2012)
• CROI 2012 Really Rapid Review -- With CROI 2013 Dates! (March 15, 2012)
• A Truly Bizarre "Systematic" Review (February 26, 2012)
  A surprising "systematic" review of Atripla research from Cochrane Summaries seems to leave out an awful lot of the system.
• Hepatitis C and the "Retooling" of HIV/ID Specialists (February 23, 2012)
• Boceprevir/PI Interaction: A "Dear Doctor" Letter We Didn't Want to Get (February 10, 2012)
• More on Low (but Detectable) Viral Loads -- Is Knowing This Useful? (February 3, 2012)
• Generic Lamivudine Has Arrived (January 22, 2012)
• Journal Club: In Early HIV Infection, Little Reason to Delay Therapy (January 8, 2012)
• No HIV in Pepsi? Now THAT'S a Relief (December 14, 2011)
• Who Should Care for the Aging HIV Patient? Everything Old Is ... Oh You Know (November 21, 2011)
• HCV Treatment Studies at AASLD: Wow ... and I Mean WOW! (November 10, 2011)
• Will An Antiretroviral Patch Help Adherence? Doubtful (October 29, 2011)
• Going, Going, Gone ... HIV Treatment Failure Is Disappearing in People Who Take Their Meds (October 19, 2011)
• Spanish HIV Vaccine Story Gets Lots of Attention -- Here's Why (October 4, 2011)
• CASCADE: When to Start, (Yet) Another Take (October 3, 2011)
• Warning: Viral Replication Is Hazardous to Your Health (September 24, 2011)
• "Novel" Approaches to Initial HIV Therapy (September 6, 2011)
• A Reason to Continue Restrictive HIV Testing Laws? Not Really (August 19, 2011)
• Next Single-Pill HIV Treatment Approved, and It's Not Called "B-Tripla" (August 11, 2011)
  What's most important to know about Complera, the newest all-in-one HIV medication? Paul Sax, M.D., breaks it down.
• Why the Proposed Massachusetts HIV Testing Bill Is Bad for Patients (August 9, 2011)
• More Favorable Results on PrEP, But ... (July 14, 2011)
  Paul Sax, M.D., questions precisely what the latest encouraging results on PrEP mean in terms of providing antiretrovirals to people in mixed-status relationships.
• A Thank You to Nice Patients (July 12, 2011)
  Do ideal patients actually get better medical care from their health care providers? Paul Sax, M.D., ponders the possibility.
• Abacavir Agonistes (June 24, 2011)
  Paul Sax, M.D., summarizes several recent studies that still seek to definitively answer the question of whether Ziagen (abacavir) is associated with a greater risk of cardiovascular disease.
• More on Generic Antiretrovirals ... (June 13, 2011)
• HPTN 052 Results -- Another Win for Early HIV Therapy (May 12, 2011)
• A "New" Antiretroviral Option Quietly Enters the Market (April 25, 2011)
• Organ Transplants From HIV-Infected Donors (April 18, 2011)
• Journal Club: Even When You Think You Should Wait, It's Probably Time to Start (April 8, 2011)
• Friday Fosfomycins (March 18, 2011)
• Like It or Not, PrEP Enters the Clinic (March 11, 2011)
• Really Rapid Review of CROI 2011 -- and No CROI 2012 Dates (March 8, 2011)
• Disparities in HIV Diagnoses, and Interpreting CDC-ese (February 3, 2011)
• Wow, That Was Fast: PrEP Guidelines Appear (January 28, 2011)
• A New Antiretroviral Drug Class, and a Movie (January 20, 2011)
• Revised DHHS Guidelines, and Some Thoughts on Guidelines in General (January 11, 2011)
• Once-Daily Raltegravir "Not Non-Inferior" to Twice-Daily (November 29, 2010)
• iPrEx: First-Ever PrEP Efficacy Study Published (November 23, 2010)
  Paul Sax, M.D., offers his analysis of the study results and their real-world implications.
• Tesamorelin Is Approved (November 12, 2010)
• With HIV Medication Adherence, It's Not a Competition (October 29, 2010)
• Worlds Collide: Roberto Alomar and HIV (October 12, 2010)